news in brief
Safic-Alcan signs deal with Turkey's Marmara Ecza
![Gettyimages/pavalena](/var/wrbm_gb_food_pharma/storage/images/_aliases/wrbm_large/publications/pharmaceutical-science/in-pharmatechnologist.com/headlines/ingredients/safic-alcan-signs-deal-with-turkey-s-marmara-ecza/7465082-1-eng-GB/Safic-Alcan-signs-deal-with-Turkey-s-Marmara-Ecza.jpg)
The deal – financial terms of which were not disclosed – will see Marmara Ecza store and distribute Safic-Alcan’s range of active pharmaceutical ingredients (APIs), excipients and related chemicals from its warehouse in the capital, Istanbul.
Safic-Alcan has been building its presence in the Turkish market since 2011, when it acquired a majority stake in Interplast. Paris-based Safic-Alcan bought Interplast outright in 2016.
According to Safic-Alcan CEO Philippe Combette “This joint venture is in line with our strategy of global sector diversification and is a further step in bolstering our presence in Turkey.”
Marmara Ecza distributes products for companies like Evonik, Meggle, Ashland and Roquette to manufacturers in the pharmaceutical, cosmetic and chemical industries.